ICOVIR-5

AXP000050.1 · Oncolytic virus

Platform
adenovirus (Ad5, E2F-1 promoter-driven E1A-Delta24, RGD fiber)
Originator
IDIBELL / Institut Catala d'Oncologia (Ramon Alemany)
Sponsor
Hospital Infantil Universitario Nino Jesus

Names

NameTypeSource
ICOVIR-5preferred name, codecurator, ctgov
AloCELYVIR ambiguoussynonymncit
Celyvir ambiguoussynonymncit

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 (ICOVIR-5)
Replication
conditionally replicating
Modifications
E2F-1 promoter drives E1A-Delta24; RGD-4C fiber; Sp1 insulator
Route
intravenous
Carrier
bone marrow mesenchymal stromal cells (Celyvir, AloCELYVIR)
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT01864759Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic MelanomaCompletedPhase 12013-01-112016-12-2014Locally Advanced or Metastatic Melanoma
NCT01844661Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.CompletedPhase 1/22013-012014-1220Children; Metastases; Solid Tumors
Unconfirmed matches (2)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT05047276Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal MelanomaUnknownPhase 1/22021-10-012023-06-3016Uveal Melanoma, Metastaticintervention named: AloCELYVIR
NCT04758533Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in MonotherapyActive not recruitingPhase 1/22021-04-192026-0413Diffuse Intrinsic Pontine Glioma; Medulloblastoma, Childhood, Recurrentintervention named: AloCELYVIR

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 33737338Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.Journal for immunotherapy of cancer2021cited by trial NCT01844661
PMID 32028001Longitudinal Monitoring of Gd-DTPA Following Convection Enhanced Delivery in the Brainstem.World neurosurgery2020name in abstract: ICOVIR-5
PMID 32053771First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.Molecular therapy : the journal of the American Society of Gene Therapy2020cited by trial NCT01844661
PMID 30234393A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.Human gene therapy2019name in title: ICOVIR-5
PMID 24327128Superselective intracerebral catheterization for administration of oncolytic virotherapy in a case of diffuse intrinsic pontine glioma.Journal of pediatric hematology/oncology2014name in abstract: ICOVIR-5
PMID 20168350Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.Cancer gene therapy2010name in abstract: ICOVIR-5

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41705010A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy.Cureus2026name in abstract: ICOVIR-5
PMID 41741902Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors.Journal of neuro-oncology2026name in abstract: ICOVIR-5
PMID 39290319Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy.Molecular therapy. Oncology2024name in abstract: ICOVIR-5
PMID 32457488AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.Cancer gene therapy2021name in abstract: ICOVIR-5
PMID 32354143Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.Cancers2020name in abstract: ICOVIR-5
PMID 30322950Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells.Molecular cancer therapeutics2019name in abstract: ICOVIR-5
PMID 30066102Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.Cancer immunology, immunotherapy : CII2018name in abstract: ICOVIR-5
PMID 28525366Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.Oncotarget2017name in abstract: ICOVIR-5
PMID 20179683Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.Molecular therapy : the journal of the American Society of Gene Therapy2010name in abstract: ICOVIR-5
PMID 21381281[The use of oncolytic adenovirus for the treatment of cancer].Methods and findings in experimental and clinical pharmacology2010name in abstract: ICOVIR-5
PMID 17557108Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo.Cancer gene therapy2007name in title: ICOVIR-5
PMID 17579575Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.Molecular therapy : the journal of the American Society of Gene Therapy2007name in title: ICOVIR-5
PMID 17804740ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.Cancer research2007name in title: ICOVIR-5
Unconfirmed matches (2)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 42458857Celyvir: Oncolytic Virotherapy with Mesenchymal Stromal Cells. From Concept to Clinical Translation.Human gene therapy2026name in title: Celyvir
PMID 39946782Exploring neuroblastoma's cellular microenvironment: A novel approach using cellular automata to model Celyvir treatment.Computers in biology and medicine2025name in title: Celyvir

Notes

Given both naked (phase I melanoma, NCT01864759) and carried in bone-marrow mesenchymal stromal cells as Celyvir (autologous, NCT01844661) and AloCELYVIR (allogeneic, NCT04758533). Treated here as one program with a carrier, not three; a curator may prefer to split the cell products out.

How to cite

ICOVIR-5 (AXP000050.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000050.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.